JPMorgan lowered the firm’s price target on Endava (DAVA) to $10 from $13 and keeps a Neutral rating on the shares. The company reported a fiscal Q1 miss and guidance cut, the analyst tells investors in a research note. The firm sees limited share upside until consensus estimates are “de-risked.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVA:
- Endava price target lowered to $9 from $12 at Needham
- Endava Reports Q1 FY2026 Results with Strategic Partnership Highlight
- Endava price target lowered to $15 from $18 at Guggenheim
- Endava Reports Q1 FY2026 Revenue Decline Amid Challenges
- Endava’s Earnings Call: Strategic Wins Amid Financial Hurdles